Ategrity Specialty grants 125K options to exec
ASIC’s President and Chief Underwriting Officer received two long-dated stock option grants with staged vesting schedules.
Rhea-AI Filing Summary
Ategrity Specialty Insurance Co Holdings (ASIC) reported that President and Chief Underwriting Officer Chris Schenk received two grants of stock options on September 4, 2026. Each grant covers 62,829 options for common stock with an exercise price of $27.40 per share and an expiration date of September 4, 2036.
One option grant vests in five equal annual installments beginning on September 4, 2027, and the other vests in five equal annual installments beginning on September 4, 2028. No Rule 10b5-1 trading plan is reported for these awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 125,658 shares
Grant/Award
2 txns
Insider
Schenk Chris
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 62,829 | $0.00 | $0.00 |
| Grant/Award | Stock Option F2 | 62,829 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 125,658 contracts (Direct)
Footnotes (2)
- F1. The option vests in five equal annual installments beginning on September 4, 2028.
- F2. The option vests in five equal annual installments beginning on September 4, 2027.
Key Figures
Options granted (first grant): 62,829 options
Options granted (second grant): 62,829 options
Total options granted: 125,658 options
+4 more
7 metrics
Options granted (first grant)
62,829 options
Grant of stock options to Chris Schenk on September 4, 2026
Options granted (second grant)
62,829 options
Second grant of stock options to Chris Schenk on September 4, 2026
Total options granted
125,658 options
Combined total of both option grants reported for September 4, 2026
Exercise price
$27.40 per share
Exercise price for each stock option grant
Expiration date
September 4, 2036
Expiration date for both stock option grants
Vesting start (first grant)
September 4, 2027
First grant vests in five equal annual installments beginning on this date
Vesting start (second grant)
September 4, 2028
Second grant vests in five equal annual installments beginning on this date
Key Terms
stock option, exercise price, vesting, expiration date, +1 more
5 terms
stock option financial
"reported that President and Chief Underwriting Officer Chris Schenk received two grants of stock options"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"Each grant covers 62,829 options for common stock with an exercise price of $27.40 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"One option grant vests in five equal annual installments beginning on September 4, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"an exercise price of $27.40 per share and an expiration date of September 4, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for these awards"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What did ASIC insider Chris Schenk report on this Form 4 filing?
Chris Schenk, President and Chief Underwriting Officer of Ategrity Specialty Insurance Co Holdings (ASIC), reported receiving two grants of stock options for common stock on September 4, 2026, as part of his equity compensation.
How many ASIC stock options were granted to Chris Schenk?
Chris Schenk received two separate grants of 62,829 stock options each, for a total of 125,658 options, all relating to ASIC common stock.
What is the exercise price and expiration date of the ASIC options granted?
Each of Chris Schenk’s option grants has an exercise price of $27.40 per share and an expiration date of September 4, 2036, providing a long-dated opportunity to purchase ASIC common stock.
What are the vesting schedules for the ASIC options granted to Chris Schenk?
One grant of 62,829 options vests in five equal annual installments beginning on September 4, 2027. The other grant of 62,829 options vests in five equal annual installments beginning on September 4, 2028.
Were the ASIC option grants to Chris Schenk made under a Rule 10b5-1 plan?
No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with these stock option grants to Chris Schenk.
AI-generated analysis. How Rhea-AI works. Not financial advice.
